NCT02084693

Brief Summary

Evaluate Survivorship for the Biomet® Comprehensive® Reverse Shoulder Mini Baseplate.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2013

Longer than P75 for all trials

Geographic Reach
1 country

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2013

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 5, 2014

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 12, 2014

Completed
5.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2019

Completed
Last Updated

July 5, 2019

Status Verified

June 1, 2018

Enrollment Period

5.3 years

First QC Date

March 5, 2014

Last Update Submit

July 3, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Survivorship

    The primary objective of this prospective clinical data collection is to evaluate survivorship for the Biomet® Comprehensive® Reverse Shoulder Mini Baseplate.

    1 year

Secondary Outcomes (8)

  • Adverse Events (including dislocation)

    3 year

  • Constant-Murley Shoulder Score

    3 year

  • Radiographic Evaluation (Plain X-ray and CT)

    3 year

  • Scapular Notching

    3 year

  • Constant-Murley Shoulder Score

    1 year

  • +3 more secondary outcomes

Study Arms (1)

COMPREHENSIVE

Evaluate Survivorship for the Biomet® Comprehensive® Reverse Shoulder Mini Baseplate.

Device: COMPREHENSIVE

Interventions

Comprehensive® Reverse Shoulder products are indicated for use in patients whose shoulder joint has a grossly deficient rotator cuff with severe arthropathy and/or previously failed shoulder joint replacement with a grossly deficient rotator cuff.

COMPREHENSIVE

Eligibility Criteria

Age60 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Therefore, patients / cases to be included in this study shall utilize the following inclusion criteria: 1. The patient must be anatomically and structurally suited to receive the implants and a functional deltoid muscle is necessary. 2. Grossly deficient rotator cuff with severe arthropathy and/or * Previously failed shoulder joint replacement with a grossly deficient rotator cuff. * Primary total shoulder replacement for the relief of pain and significant disability due to gross rotator cuff deficiency, or * Fracture total shoulder replacement for the relief of pain and significant disability due to gross rotator cuff deficiency, or * Revision total shoulder replacement for the relief of pain and significant disability due to gross rotator cuff deficiency.

You may qualify if:

  • Comprehensive Reverse Shoulder Mini Base Plate and Mini Stem in a reverse shoulder configuration.
  • The patient must be anatomically and structurally suited to receive the implants and a functional deltoid muscle is necessary.
  • Grossly deficient rotator cuff with severe arthropathy and/or
  • Previously failed shoulder joint replacement with a grossly deficient rotator cuff.
  • Primary total shoulder replacement for the relief of pain and significant disability due to gross rotator cuff deficiency, or
  • Fracture total shoulder replacement for the relief of pain and significant disability due to gross rotator cuff deficiency, or
  • Revision total shoulder replacement for the relief of pain and significant disability due to gross rotator cuff deficiency.

You may not qualify if:

  • Absolute contraindications include infection, sepsis, and osteomyelitis.
  • Relative contraindications include:
  • Uncooperative patient or patient with neurologic disorders who is incapable or unwilling to follow directions.
  • Osteoporosis.
  • Metabolic disorders which may impair bone formation.
  • Osteomalacia.
  • Distant foci of infections which may spread to the implant site.
  • Rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Bunndang Seoul Nat'l Univ. Hospital

Seongnam-si, Seongnam, South Korea

Location

Ewha Womans University Mokdong Hospital

Seoul, South Korea

Location

Gangnam Sacred Heart Hospital

Seoul, South Korea

Location

Kyung Hee Univ Hospital

Seoul, South Korea

Location

Samsung Medical Center

Seoul, South Korea

Location

MeSH Terms

Conditions

Rotator Cuff Tear ArthropathyOsteoporosisOsteomalacia

Interventions

Comprehensive Metabolic Panel

Condition Hierarchy (Ancestors)

ChondrocalcinosisArthritisJoint DiseasesMusculoskeletal DiseasesCrystal ArthropathiesBone Diseases, MetabolicBone DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesRicketsCalcium Metabolism DisordersVitamin D DeficiencyAvitaminosisDeficiency DiseasesMalnutritionNutrition Disorders

Intervention Hierarchy (Ancestors)

Blood Chemical AnalysisClinical Chemistry TestsClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisInvestigative Techniques

Study Officials

  • Joo Han Oh, Ph.D.

    Bundang Seoul Nat'l University Hospital

    PRINCIPAL INVESTIGATOR
  • Sang Jin Shin, Ph.D.

    Ewha Womans University Mokdong Hospital

    PRINCIPAL INVESTIGATOR
  • Jae Chul Yoo, Ph. D.

    Samsung Medical Center

    PRINCIPAL INVESTIGATOR
  • Yong Girl Rhee, Ph.D.

    Kyung Hee Univ. Hospital

    PRINCIPAL INVESTIGATOR
  • Kyu Chul Noh, Ph.D.

    Gangnam Sacred Heart Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 5, 2014

First Posted

March 12, 2014

Study Start

December 1, 2013

Primary Completion

April 1, 2019

Study Completion

June 1, 2019

Last Updated

July 5, 2019

Record last verified: 2018-06

Data Sharing

IPD Sharing
Will not share

Locations